FDA knocks back Mallinckrodt's kidney drug terlipressin

Manufacturing problems seem to have scuppered Mallinckrodt's hopes of bringing the first approved drug to market in the US for hepatorenal syndrome (HRS), a life-threatening condition that

Mallinckrodt moves closer to resolving its opioid liability ...

Mallinckrodt looks like it could join Purdue Pharma in reaching a settlement in its bankruptcy proceedings related to opioid litigation, after years of legal wrangling.

AI device cleared by FDA to spot lesions during colonoscopy

The FDA has approved the first artificial intelligence-powered device that can be used to help identify colorectal lesions during the millions of colonoscopies carried out each year in the

Mallinckrodt’s liver disease drug terlipressin edges FDA adv...

An FDA advisory committee has narrowly voted in favour of approval of Mallinckrodt’s terlipressin for hepatorenal syndrome type 1 (HRS-1), after the agency questioned the findi

Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 tr...

Mallinckrodt proposes $1.6bn deal to settle opioid litigatio...